Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus

Author： Menghini R. Uccioli L. Vainieri E. Pecchioli C. Casagrande V. Stoehr R. Cardellini M. Porzio O. Rizza S. Federici M.

Publisher： Springer Publishing Company

ISSN： 0940-5429

Source： Acta Diabetologica, Vol.50, Iss.6, 2013-12, pp. : 907-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitus

By Forst Thomas Pfützner Andreas

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 1, 2013-01 ,pp. : 21-35

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

By Raz I. Hanefeld M. Xu L. Caria C. Williams-Herman D. Khatami H.

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2564-2571

Springer Publishing Company

Access to resources Recommend Favorite

Postprandial Hyperglycemia in Patients with Type 2 Diabetes Mellitus

By Sudhir R. Mohan V.

Treatments in Endocrinology, Vol. 1, Iss. 2, 2002-02 ,pp. : 105-116

Adis International

Access to resources Recommend Favorite

Management of Obesity in Patients with Type 2 Diabetes Mellitus

Current Diabetes Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 95-101

Bentham Science Publishers

Access to resources Recommend Favorite

Managing Type 2 Diabetes Mellitus in Patients with Obesity

By Hauner Hans

Treatments in Endocrinology, Vol. 3, Iss. 4, 2004-01 ,pp. : 223-232

Adis International

Access to resources Recommend Favorite